SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-07-21 |
| Reported value | $131,686,000 |
| Positions | 34 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| STATE STREET SPDR S&P BIOTECH | XBI | S&P BIOTECH | $19,160,000 | 150,000 |
| CARDINAL HEALTH | CAH | COM | $5,071,000 | 24,000 |
| CALL- BSX 100 @ 75 EXP 04/17/2026 | Unresolved | CALL | $5,020,000 | 800 |
| JOHNSON&JOHNSON | JNJ | COM | $4,889,000 | 20,000 |
| MERCK & CO | MRK | COM | $4,812,000 | 40,000 |
| CENCORA INC | COR | COM | $4,712,000 | 15,000 |
| ELI LILLY & CO | LLY | COM | $4,599,000 | 5,000 |
| WATERS CORP | WAT | COM | $4,467,000 | 15,000 |
| VERTEX PHARMACEUTICALS INC. | VRTX | COM | $4,465,000 | 10,000 |
| INTUITIVE SURG | ISRG | COM NEW | $4,149,000 | 9,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.